Green Lifescience Co., Ltd. (KOSDAQ:114450)

Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	14,219	13,407	9,068	6,348	2,814	3,388
Short-Term Investments	21.75	25.46	127.56	5,669	2,300	7,800
Trading Asset Securities	5,851	3,754	3,690	2,436	11,835	5,015
Cash & Short-Term Investments	20,092	17,186	12,885	14,453	16,949	16,203
Cash Growth	71.48%	33.38%	-10.85%	-14.73%	4.60%	7.08%
Accounts Receivable	6,751	6,893	4,997	1,451	2,509	3,450
Other Receivables	80.39	35.99	38.99	8.54	333.75	114.13
Receivables	6,831	6,929	5,036	1,460	2,843	3,564
Inventory	8,831	8,418	3,905	5,311	6,014	5,732
Prepaid Expenses	50.17	49.49	52.01	160.15	42.62	735.77
Other Current Assets	55.95	94.51	112.3	328.73	595.04	657.55
Total Current Assets	35,860	32,678	21,991	21,712	26,443	26,892
Property, Plant & Equipment	14,968	12,560	13,533	13,256	27,112	36,846
Long-Term Investments	-	-	-	-	-	7,381
Other Intangible Assets	402.41	94.74	97.47	2.81	87.92	181.72
Long-Term Deferred Tax Assets	-	-	-	-	-	619.37
Long-Term Deferred Charges	151.91	170.68	11.92	24.91	-	-
Other Long-Term Assets	7,973	9,361	9,339	8,833	8,788	57.44
Total Assets	59,356	54,864	44,972	43,828	62,432	71,977

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5,761	7,610	2,151	-	-	4,114
Accrued Expenses	553.45	37.76	5.62	-	-	2.12
Short-Term Debt	4,000	6,500	4,800	4,800	6,488	7,433
Current Portion of Leases	161.82	124.18	41.01	104.04	117.85	104.86
Current Unearned Revenue	-	26.1	46.72	34	34	-
Other Current Liabilities	1,860	1,713	1,270	2,455	2,796	3,588
Total Current Liabilities	12,336	16,011	8,314	7,394	9,437	15,242
Long-Term Leases	318.61	367.99	530.9	28.82	18.27	57.76
Pension & Post-Retirement Benefits	269.15	146.95	357.51	443.95	331.2	371.39
Other Long-Term Liabilities	80.47	50.34	21.61	8.12	6.78	8.19
Total Liabilities	14,505	16,576	9,224	7,874	9,793	15,679

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	10,000	10,000	10,000	10,000	7,500	7,500
Additional Paid-In Capital	15,844	15,777	15,025	36,425	38,956	38,956
Retained Earnings	19,007	12,871	12,746	-10,105	6,232	9,680
Treasury Stock	-	-360.3	-2,023	-366.29	-	-
Comprehensive Income & Other	-	-0	-0	0	-48.7	162.39
Shareholders' Equity	44,851	38,288	35,748	35,954	52,639	56,298
Total Liabilities & Equity	59,356	54,864	44,972	43,828	62,432	71,977

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5,980	6,992	5,372	4,933	6,624	7,595
Net Cash (Debt)	14,111	10,194	7,513	9,520	10,324	8,608
Net Cash Growth	267.37%	35.68%	-21.08%	-7.79%	19.93%	-1.28%
Net Cash Per Share	720.54	531.08	390.48	476.93	516.22	430.42
Filing Date Shares Outstanding	20	19.84	19.09	19.83	20	20
Total Common Shares Outstanding	20	19.84	19.09	19.83	20	20
Working Capital	23,523	16,667	13,677	14,319	17,007	11,651
Book Value Per Share	2242.55	1930.08	1872.83	1812.66	2631.95	2814.92
Tangible Book Value	44,449	38,193	35,650	35,951	52,551	56,117
Tangible Book Value Per Share	2222.43	1925.30	1867.72	1812.52	2627.55	2805.83
Land	9,840	8,450	8,450	8,425	8,329	7,923
Buildings	7,083	7,081	7,918	7,846	16,077	13,381
Machinery	36,360	35,863	35,677	35,434	38,766	39,913
Construction In Progress	1,100	332.16	-	23.1	207.03	11,769

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 17, 2026

Data Sources Report a data error